Aim: Obesity frequently co-exists with hypertension (HTN). Hypothalamus neuropeptides
such as neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) interact …

Aim: Obesity and hypertension frequently coexist and both represent important risk factors
for cardiovascular disease. The mechanisms implicated in the regulation of food intake have …

To study the relations between neuropeptide Y (NPY) and age, gender, blood pressure (BP)
and risk Factors for cardiovascular disease and the renin-angiotensin system, we performed …

Objective Neuropeptide Y (NPY) is released during sympathetic stimulation and mediates
the central effects of the adipostatic hormone leptin. The plasma concentration of NPY and …

Purpose: To evaluate whether neuropeptide Y (NPY) is likely to be relevant as a regulator of
cardiovascular function in general and of blood pressure control in arterial hypertension in …

Objective: Neuropeptide Y is a co-transmitter with noradrenaline in sympathetic neurons
supplying arteries and veins with potent contractile effects. To investigate the role of …

Neuropeptide-Y (NPY) is a peptide proposed to modulate the effect of the sympathetic
nervous system on blood pressure control and contribute to the development of essential …

Neuropeptide Y (NPY) is generally considered to play an important role in central and
peripheral neural regulation, cardiovascular control and blood pressure homeostasis [1] …

Neuropeptide-Y (NPY) is a sympathetic cotransmitter, which causes vasoconstriction,
decreases coronary blood flow and decreases cardiac output. Circulating immunoreactive …

Neuropeptide Y (NPY) is a polypeptide containing 36 amino acids. Circulating NPY
originates predominantly from the sympatho-adrenomedullary nervous system. It has a …